| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/09/1997 | EP0767172A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection |
| 04/09/1997 | EP0767167A1 Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 04/09/1997 | EP0766965A1 Immunosuppressive agents |
| 04/09/1997 | EP0766745A1 Monoclonal antibody specific for human 4-1bb and cell line producing same |
| 04/09/1997 | EP0766685A1 Aryl, alkyl, alkenyl, and alkynylmacrolides |
| 04/09/1997 | EP0766683A1 Novel substituted purinyl derivatives with immunomodulating activity |
| 04/09/1997 | EP0766676A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766668A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 04/09/1997 | EP0766569A1 Aav capsid vehicles for molecular transfer |
| 04/09/1997 | EP0766565A1 Medical use of bromelain |
| 04/09/1997 | EP0766559A1 Cannabinoid receptor antagonists |
| 04/09/1997 | EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 04/09/1997 | EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/09/1997 | CN1147258A Process for preparation of 4-amino-'delta' 4-3-ketosteroids via 4-nitro-'delta'4-3-ketosteroids |
| 04/09/1997 | CN1147253A Novel crystal forms of 1-[5-methanesulfonamido indolyl-2-carbonyl]-4-[3(1-methylethylamino)-2-pyridinyl] piperazine |
| 04/09/1997 | CN1034503C Pyrazolopyrimidinone antianginal agent preparing process |
| 04/09/1997 | CN1034501C Method for preparing (Benzhydryloxyethylpiperidyl) aliphatic acid derivs. |
| 04/08/1997 | US5618939 Reacting of an amine nucleophile with an activated glycidylcompound in presence of a strong base at low temperature |
| 04/08/1997 | US5618938 Process for preparing stereo isomers of neurokinin receptor antagonists |
| 04/08/1997 | US5618557 Prophylactic treatment of allergic contact dermatitis |
| 04/03/1997 | WO1997012035A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | WO1997011712A1 Ribosome fraction and composition containing same |
| 04/03/1997 | WO1997011710A1 Use of hyaluronic acid as an immunosuppressant |
| 04/03/1997 | WO1997011668A2 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 04/03/1997 | WO1997011667A2 Therapeutic applications using horse serum |
| 04/03/1997 | WO1997011666A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 04/03/1997 | WO1997011607A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | WO1997011605A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | CA2233445A1 2-mercaptoethanolamine, copper di-isopropyl salicylate, and related compounds |
| 04/03/1997 | CA2233278A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | CA2233040A1 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | CA2233015A1 Therapeutic applications using horse serum |
| 04/03/1997 | CA2232815A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | CA2231764A1 Tumor necrosis factor alpha (tnf-.alpha.) inhibiting pharmaceuticals |
| 04/02/1997 | EP0765936A1 Cloning of mite allergens |
| 04/02/1997 | EP0765871A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765667A1 Ribosomal fraction and composition containing it |
| 04/02/1997 | EP0765392A1 Interleukin-5 specific recombinant antibodies |
| 04/02/1997 | EP0765386A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765329A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765320A1 Benzimidazolone derivatives with central dopaminergic activity |
| 04/02/1997 | EP0765305A1 Anti-inflammatory compounds |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765165A1 Constrained peptides |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0656773B1 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions |
| 04/02/1997 | EP0495008B1 Vaccine conjugate for treatment of avian diseases |
| 04/02/1997 | CN1146772A Synthetic peptide based immunogens for the treatment of allergy |
| 04/02/1997 | CN1146768A Process for making an epoxide |
| 04/02/1997 | CN1146351A Pellet with immunity detoxication function and preparation method |
| 04/01/1997 | US5616724 Fused pyrrolo[2,3-c]carbazole-6-ones |
| 04/01/1997 | US5616614 Useful in treatment of disorders linked to abnormal melatonin activity |
| 04/01/1997 | US5616612 Therapy for cancer, aids, anemia, infections |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | US5616554 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 04/01/1997 | CA2042426C Dietary fiber, its process and physiologically active composition containing the same as an active ingredient |
| 04/01/1997 | CA1339032C Forms of colony stimulating factor-1 |
| 03/29/1997 | CA2186717A1 Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011163A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/27/1997 | WO1997011093A2 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | WO1997011079A1 Novel imidazole lipoxygenase inhibitors |
| 03/27/1997 | WO1997011069A1 Heterocyclic compounds as bradykinin antagonists |
| 03/27/1997 | WO1997010844A1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010834A1 Bioactive factors of aloe vera plants |
| 03/27/1997 | WO1997010806A1 Aerosol compositions |
| 03/27/1997 | WO1997010712A1 Inhibition of tumor necrosis factor alpha |
| 03/27/1997 | WO1997010711A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/27/1997 | WO1997005859A3 Use of alicyclic diamines as immunomodulators |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/27/1997 | CA2232515A1 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | CA2232301A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/27/1997 | CA2230119A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 03/26/1997 | EP0764637A2 2-Cyano-3-mercaptocrotonamides |
| 03/26/1997 | EP0764273A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 03/26/1997 | EP0764203A1 Methods for selectively stimulating proliferation of t cells |
| 03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
| 03/26/1997 | EP0764167A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764163A1 Tachykinin (nk 1) receptor antagonists |
| 03/26/1997 | EP0764152A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 03/26/1997 | EP0764029A1 Proteinaceous adjuvants |
| 03/26/1997 | EP0649405B1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 03/26/1997 | CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146156A Means for treating auto-immune diseases and method of treatment |
| 03/26/1997 | CN1145895A New amido-ethyl substituted fluorene compound and its prepn. |
| 03/25/1997 | US5614652 Cytotoxic, palladium disposed within an iron oxide matrix |
| 03/25/1997 | US5614625 Collagenase inhibitors |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614555 Amidinophenol derivatives |